文献速递膀胱癌与上尿路尿路上皮癌

接受根治性膀胱切除术的变异组织学尿路上皮癌患者循环肿瘤细胞的检测及其肿瘤学影响

Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.
PubMed 文献 · BJU Int · 2017-02-09

该前瞻性研究纳入188例未接受新辅助化疗、行根治性膀胱切除术的膀胱尿路上皮癌患者,术前用CellSearch系统检测循环肿瘤细胞(CTC)。变异组织学占25.0%,以鳞状细胞分化最常见(16.5%)。中位随访25个月,CTC的存在而非变异组织学是疾病复发(HR 3.45)和癌症特异性死亡(HR 2.62)的独立预测因子。

要点

  • 188例根治性膀胱切除术前患者中,纯与变异组织学者CTC检出率分别为21.3%与25.5%。
  • 中位随访25个月,CTC存在与无复发生存和癌症特异性生存降低相关(成对P≤0.016)。
  • 多因素分析中CTC存在是复发(HR 3.45)和癌症特异性死亡(HR 2.62)的独立预测因子。

核心结论

  • 根治性膀胱切除术前约四分之一的纯或变异组织学尿路上皮癌患者可检出CTC,校正组织学亚型后CTC是结局的独立预测因子。
  • 前瞻性数据证实非鳞状细胞分化尿路上皮癌对结局有不利影响。

研究设计与样本

  • 前瞻性收集188例接受根治性膀胱切除术且未行新辅助化疗的膀胱尿路上皮癌患者数据。
  • 病理标本经仔细复核分为纯与变异尿路上皮癌组织学。
  • 术前采集7.5 mL血样,用CellSearch系统(Janssen,Raritan,NJ,USA)检测CTC。

主要发现

  • 变异尿路上皮癌组织学见于47例(25.0%),最常见为鳞状细胞分化(16.5%)。
  • 纯与变异组织学患者中CTC分别见于30例(21.3%)和12例(25.5%)。
  • 中位随访25个月,CTC存在与非鳞状细胞分化与无复发生存和癌症特异性生存降低相关(成对P≤0.016)。
  • 无CTC患者无论组织学如何,无复发生存均优于任何组织学类型的有CTC患者(成对P<0.05)。
  • 多因素分析中,CTC存在而非变异组织学是疾病复发的独立预测因子(HR 3.45;P<0.001)和癌症特异性死亡的独立预测因子(HR 2.62;P=0.002)。

临床怎么用

  • 作者认为,在校正组织学亚型后CTC是结局的独立预测因子。
  • 作者指出,前瞻性数据证实非鳞状细胞分化尿路上皮癌对结局有不利影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate for the presence of circulating tumour cells (CTC) in patients with variant urothelial carcinoma of the bladder (UCB) histology treated with radical cystectomy (RC), and to determine their impact on oncological outcomes. PATIENTS AND METHODS: We prospectively collected data of 188 patients with UCB treated with RC without neoadjuvant chemotherapy. Pathological specimens were meticulously reviewed for pure and variant UCB histology. Preoperatively collected blood samples (7.5 mL) were analysed for CTC using the CellSearch® system (Janssen, Raritan, NJ, USA). RESULTS: Variant UCB histology was found in 47 patients (25.0%), most frequently of squamous cell differentiation (16.5%). CTC were present in 30 patients (21.3%) and 12 patients (25.5%) with pure and variant UCB histology, respectively. At a median follow-up of 25 months, the presence of CTC and non-squamous cell differentiation were associated with reduced recurrence-free survival (RFS) and cancer-specific survival (pairwise P ≤ 0.016). Patients without CTC had better RFS, independent of UCB histology, than patients with CTC with any UCB histology (pairwise P < 0.05). In multivariable analyses, the presence of CTC, but not variant UCB histology, was an independent predictor for disease recurrence [hazard ratio (HR) 3.45; P < 0.001] and cancer-specific mortality (HR 2.62; P = 0.002). CONCLUSION: CTC are detectable in about a quarter of patients with pure or variant UCB histology before RC, and represent an independent predictor for outcomes, when adjusting for histological subtype. In addition, our prospective data confirm the unfavourable influence of non-squamous cell-differentiated UCB on outcomes.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Soave A, Riethdorf S, Dahlem R, et al. Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy. BJU Int. 2017. PMID: 28182321. doi:10.1111/bju.13782

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。